Effect of nicotine polyestex gum on smoking cessation and quality of life

Journal of the Medical Association of Thailand

Volumn 91, Issue 11, 2008, Pages 1656-1662

  Rungruanghiranya, Suthat ^a   Ekpanyaskul, Chatchai ^a   Hattapornsawan, Yongyos ^b   Tundulawessa, Yongyuth ^a  

^a SRINAKHARINWIROT UNIVERSITY   (Thailand)

^b Department of Surgery   (Thailand)

Author keywords

Nicotine dependence; Nicotine gum; Quality of life; Smoking cessation

Indexed keywords

NICOTINE; NICOTINE GUM; PLACEBO;

ABSTINENCE; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DYSPEPSIA; FEMALE; HEALTH CARE ORGANIZATION; HUMAN; JAW DISEASE; MALE; MOUTH PAIN; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SMOKING CESSATION; TOBACCO DEPENDENCE;

ADULT; CHEWING GUM; DOUBLE-BLIND METHOD; HEALTH STATUS INDICATORS; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; NICOTINE; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; SMOKING; SMOKING CESSATION; YOUNG ADULT;

EID: 57149106979     PISSN: 01252208     EISSN: 01252208     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. World Health Organization. WHO Report on the global tobacco epidemic 2008: The MPOWER package. Geneva: WHO; 2008.
2. A clinical practice guideline for treating tobacco use and dependence: A US Public Health Service report. The Tobacco Use and Dependence Clinical Practice Guideline Panel, Staff, and Consortium Representatives. JAMA 2000; 283: 3244-54.
3. Schroeder SA. What to do with a patient who smokes. JAMA 2005; 294: 482-7.
4. West R, McNeill A, Raw M. Smoking cessation guidelines for health professionals: an update. Health Education Authority. Thorax 2000; 55: 987-99.
5. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 1991; 86: 1119-27.
6. World Health Organization. The World Health Organization quality of life (WHOQOL)-BREF. Geneva: WHO; 2004.
7. The World Health Organization. Quality of Life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med 1995; 41: 1403-9.
8. O'Carroll RE, Smith K, Couston M, Cossar JA, Hayes PC. A comparison of the WHOQOL-100 and the WHOQOL-BREF in detecting change in quality of life following liver transplantation. Qual Life Res 2000; 9: 121-4.
9. Herrera N, Franco R, Herrera L, Partidas A, Rolando R, Fagerstrom KO. Nicotine gum, 2 and 4 mg, for nicotine dependence. A double-blind placebo-controlled trial within a behavior modification support program. Chest 1995; 108: 447-51.
10. Jarvis MJ, Raw M, Russell MA, Feyerabend C. Randomised controlled trial of nicotine chewing-gum. Br Med J (Clin Res Ed) 1982; 285: 537-40.
11. Russell MA, Wilson C, Feyerabend C, Cole PV. Effect of nicotine chewing gum on smoking behaviour and as an aid to cigarette withdrawal. Br Med J 1976; 2: 391-3.
12. Wu P, Wilson K, Dimoulas P, Mills EJ. Effectiveness of smoking cessation therapies: a systematic review and meta-analysis. BMC Public Health 2006; 6: 300.
13. Tudulawesa Y, Chutrtong W, Disataporn T, Leossrisuksun S, Chantaarnon P, Intapichai S. The study of nicotine releasing factors for chewing gum polymer. Srinakharinwirot University Science Journal 2006; 22: 21-33.
14. Erickson SR, Thomas LA, Blitz SG, Pontius LR. Smoking cessation: a pilot study of the effects on health-related quality of life and perceived work performance one week into the attempt. Ann Pharmacother 2004; 38: 1805-10.
15. Zillich AJ, Ryan M, Adams A, Yeager B, Farris K. Effectiveness of a pharmacist-based smoking-cessation program and its impact on quality of life. Pharmacotherapy 2002; 22: 759-65.